Cytokinetics: Fourth Quarter Financial Results Overview

Cytokinetics Inc. Reports Fourth Quarter Financial Results

Cytokinetics Inc., headquartered in South San Francisco, California, announced a net loss of $183 million for the fourth quarter.

During this period, the company recorded a loss of $1.50 per share.

These figures fell short of Wall Street projections, as analysts surveyed by Zacks Investment Research had anticipated a loss of $1.48 per share.

However, the biopharmaceutical firm generated $17.8 million in revenue for the quarter, surpassing analysts’ expectations, which averaged $3.9 million according to Zacks.

For the full year, Cytokinetics reported a total loss of $785 million, or $6.54 per share, with annual revenue reaching $88 million.

Financial data was provided by Zacks Investment Research and this article was produced by Automated Insights.